{"id":"W4383872109","doi":"10.1080/13696998.2023.2234776","title":"Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis Portugal","keywords":"Medicine; Bosutinib; Myeloid leukemia; Chronic care; Health care; Chronic disease; Internal medicine; Oncology; Intensive care medicine; Imatinib; Dasatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001275597,0.0002989766,0.0009715086,0.0005132447,0.0001074167,0.0000343876,0.0003478915,0.0002912339,0.0005536515],"category_scores_gemma":[0.0006732378,0.0002226153,0.0001483292,0.000536149,0.0001387112,0.0002177727,0.0001078241,0.0009164658,0.00004829074],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01943538,"about_ca_system_score_gemma":0.01881802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009811723,"about_ca_topic_score_gemma":0.001447077,"domain_scores_codex":[0.9965675,0.0001305093,0.001437048,0.0003819167,0.0008100349,0.0006729154],"domain_scores_gemma":[0.99752,0.0002875102,0.0009109137,0.0003817056,0.0001383097,0.0007615058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00422347,0.0008231016,0.04294861,0.001254153,0.0004977444,0.0009227388,0.00368923,0.002816709,0.00000840036,0.00005072607,0.01752467,0.9252405],"study_design_scores_gemma":[0.2598718,0.03268094,0.2399252,0.01328808,0.0005260323,0.001678194,0.003937429,0.04702849,0.0003888962,0.00005270824,0.399306,0.001316122],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918318,0.001646372,0.00007121636,0.005133525,0.0004211293,0.0005704732,0.00002526428,0.00004859377,0.0002516372],"genre_scores_gemma":[0.9908737,0.006049945,0.0002931598,0.0009886838,0.001151399,0.00001586435,0.0002859984,0.00009495367,0.0002462853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9239243,"threshold_uncertainty_score":0.9867443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02998438724378213,"score_gpt":0.3263907657694533,"score_spread":0.2964063785256712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}